Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
127,737,167
-
Shares change
-
+10,335,222
-
Total reported value, excl. options
-
$1,253,010,027
-
Value change
-
+$99,503,608
-
Put/Call ratio
-
26%
-
Number of buys
-
89
-
Number of sells
-
-121
-
Price
-
$9.81
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2023
261 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2023.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127,737,167 shares
.
Largest 10 shareholders include BlackRock Inc. (18,876,054 shares), FEDERATED HERMES, INC. (12,655,363 shares), STATE STREET CORP (8,943,648 shares), VANGUARD GROUP INC (8,450,898 shares), Deep Track Capital, LP (6,350,000 shares), Chicago Capital, LLC (5,845,248 shares), BANK OF AMERICA CORP /DE/ (4,340,287 shares), Bain Capital Life Sciences Investors, LLC (3,915,000 shares), Fisher Asset Management, LLC (3,886,525 shares), and PFM Health Sciences, LP (3,805,370 shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.